Listed

NexPoint Real Estate Finance, Inc.: Form 10-Q for the period ended Sep 30, 2025

Filed with the SEC on Nov 13, 2025 and accepted by EDGAR at Nov 13, 2025, 16:05 ET.

Share

Management's discussion and analysis

As filed, 100,988 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following is a discussion and analysis of our financial condition and results of operations. The following should be read in conjunction with our financial statements and accompanying notes included herein and with our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 27, 2025. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those projected, forecasted, or expected in these forward-looking statements as a result of various factors, including, but not limited to, those discussed below and elsewhere in this quarterly report. See “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2024. Our management believes the assumptions underlying the Company's financial statements and accompanying notes are reasonable. However, the Company's financial statements and accompanying notes may not be an indication of our financial condition and results of operations in the future.

Overview

We are a commercial mortgage REIT incorporated in Maryland on June 7, 2019. Our strategy is to originate, structure and invest in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties and common equity investments, as well as multifamily and SFR CMBS securitizations, promissory notes, revolving credit facilities and stock warrants, or our target assets. We primarily focus on investments in real estate sectors where our senior management team has operating expertise, including in the multifamily, SFR, self-storage and life science sectors predominantly in the top 50 MSAs. In addition, we target lending or investing in properties that are stabilized or have a light-transitional business plan.

Our investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. We seek to employ a flexible and relative-value focused investment strategy and expect to re-allocate capital periodically among our target investment classes. We believe this flexibility will enable us to efficiently manage risk and deliver attractive risk-adjusted returns under a variety of market conditions and economic cycles.

We are externally managed by our Manager, a subsidiary of our Sponsor, an SEC-registered investment advisor, which has extensive real estate experience, having completed as of September 30, 2025 approximately $21.7 billion of gross real estate transactions since the beginning of 2012. In addition, our Sponsor, together with its affiliates and NexBank, is one of the most experienced global alternative credit managers managing approximately $14.4 billion of loans and debt or credit related investments as of September 30, 2025 and has managed credit investments for over 25 years. We believe our relationship with our Sponsor benefits us by providing access to resources including research capabilities, an extensive relationship network, other proprietary information, scalability, and a vast wealth of knowledge of information on real estate in our target assets and sectors.

We elected to be treated as a REIT for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2020. We also intend to operate our business in a manner that will permit us to maintain one or more exclusions or exemptions from registration under the Investment Company Act.

The U.S. government announced a comprehensive set of tariffs in the second quarter of 2025. Following the pause of certain of these tariffs, the majority of the previously announced tariffs have been implemented. The U.S. government has indicated that it could impose additional tariffs on particular countries and impose global tariffs on certain goods. Such tariffs could impact our results of operations by increasing the costs of various goods, including construction materials. Management is actively engaged with vendors and business partners to reduce financial risks of tariffs; however, the impact of such tariffs is subject to uncertainties regarding the timing of their implementation, the magnitude of such tariffs and possible exemption for certain goods, among other unknowns.

On October 15, 2021, a lawsuit (the “Bankruptcy Trust Lawsuit”) was filed by a litigation subtrust formed in connection with Highland’s bankruptcy against various persons and entities, including our Sponsor and James Dondero. On March 24, 2023, the litigation trustee filed a motion for leave to stay the Bankruptcy Trust Lawsuit, which was granted by the bankruptcy court on April 4, 2023. On June 30, 2025, the bankruptcy court approved a settlement agreement between Highland and Hunter Mountain Investment Trust (“HMIT”) pursuant to which the claims asserted in the Bankruptcy Trust Lawsuit were assigned to HMIT. HMIT subsequently filed a motion to lift the stay of the Bankruptcy Trust Lawsuit, which was granted and became effective on October 3, 2025. As of the date of this filing, the bankruptcy court has requested briefing from the parties regarding whether the court continues to have jurisdiction over the Bankruptcy Trust Lawsuit given the assignment of claims from Highland to HMIT. Briefs on this matter are due on November 18, 2025. On February 8, 2023, UBS Securities LLC and UBS AG London (collectively, “UBS”) filed a lawsuit in the Supreme Court of the State of New York, County of New York related to a default that occurred in 2009 on a warehouse facility between UBS and funds affiliated with Highland. The lawsuit makes claims against several persons and entities, including Mr. Dondero, the President of our Sponsor, seeking to collect on $1.3 billion in judgments UBS obtained against entities that were managed indirectly by Highland (the “UBS Lawsuit”). On March 7, 2023, the matter was removed to the United States District Court for the Southern District of New York. On April 6, 2023, UBS moved to have the case remanded to New York state court. The federal court remanded the state-law causes of action and retained and stayed the federal cause of action. On

February 26, 2024, several of the respondents, including Mr. Dondero, filed motions in state court to dismiss the UBS Lawsuit on various grounds. A hearing was held on July 8, 2024. The court dismissed the claims against one respondent, CLO HoldCo, Ltd., for lack of personal jurisdiction in a July 12, 2024 order. On March 26, 2025, the court entered an order denying the remaining motions to dismiss and directed the respondents to file an answer to the UBS Lawsuit within 20 days, which they did. Mr. Dondero is appealing the denial of the motion to dismiss to the Appellate Division of the Supreme Court of the State of New York. Neither the Bankruptcy Trust Lawsuit nor the UBS Lawsuit include claims related to our business or our assets or operations. Our Sponsor and Mr. Dondero have informed us they believe the Bankruptcy Trust Lawsuit has no merit, and Mr. Dondero has informed us he believes the UBS Lawsuit has no merit; we have been advised that the defendants named in each of the lawsuits intend to vigorously defend against the claims. We do not expect the Bankruptcy Trust Lawsuit or the UBS Lawsuit will have a material effect on our business, results of operations or financial condition.

Our website is located at nref.nexpoint.com. From time to time, we may use our website as a distribution channel for material company information.

Purchases and Dispositions in the Quarter

Acquisitions and Originations

The Company acquired or originated the following investments through the Subsidiary OPs in the three months ended September 30, 2025. The amounts in the table below are as of the purchase or investment date:

Investment Property Type Investment Date Outstanding Principal Amount Cost (% of Par Value) Coupon (1) Current Yield (1) Maturity Date Interest Rate Type
Common Equity Multifamily 7/8/2025 $500,000 100.0% N/A N/A N/A Fixed
Mezzanine Life Science 7/9/2025 6,533,824 100.0% 14.00% 14.00% 2/9/2027 Floating
Preferred Equity Single-family 7/10/2025 1,158,939 99.0% 13.50% 13.64% 4/28/2027 Fixed
Preferred Stock Life Science 7/17/2025 42,500,000 100.0% 16.50% 16.50% N/A Fixed
Promissory Note Single-family 7/31/2025 10,936,042 100.0% 15.00% 15.00% 7/10/2026 Fixed
Real Estate Multifamily 7/31/2025 225,513 100.0% N/A N/A N/A Fixed
Mezzanine Self-Storage 8/1/2025 3,297,500 100.0% 10.55% 10.55% 8/1/2026 Floating
Preferred Equity Marina 8/1/2025 4,480,000 100.0% 13.00% 13.00% 8/15/2035 Fixed
Mezzanine Multifamily 8/8/2025 376,794 99.0% 15.30% 15.46% 1/9/2026 Floating
Promissory Note Multifamily 9/30/2025 3,000,000 100.0% 8.00% 8.00% 9/30/2026 Fixed
$73,008,612

51

(1) Current yield and coupon as of September 30, 2025.

Redemptions and Sales

The following investments were redeemed or sold during the three months ended September 30, 2025:

Investment Property Type Investment Date Disposition Date Amortized Cost Basis Redemption/Sales Proceeds Prepayment Penalties Net Gain (Loss) on Repayment
Preferred Equity Life Science 4/6/2023 7/11/2025 $702,604 $702,604 $— $—
Real Estate Multifamily 12/31/2021 7/22/2025 29,865,383 29,865,383 — —
Preferred Equity Life Science 10/19/2022 9/26/2025 441,743 441,743 — —
Preferred Equity Multifamily 10/5/2022 9/29/2025 2,539,672 2,539,672 — —
Common Equity Multifamily 5/8/2024 9/29/2025 391,500 391,500 — —
Senior Loan Life Science 1/26/2024 9/30/2025 62,450,000 62,450,000 — —
$96,390,902 $96,390,902 $— $—

Components of Our Revenues and Expenses

Net Interest Income

Interest income. Our earnings are primarily attributable to the interest income from mortgage loans, mezzanine loan and preferred equity investments. Loan premium/discount amortization and prepayment penalties are also included as components of interest income.

Interest expense. Interest expense represents interest accrued on our various financing obligations used to fund our investments and is shown as a deduction to arrive at net interest income.

Other Income (Loss)

Change in net assets related to consolidated CMBS variable interest entities. Includes unrealized gain (loss) based on changes in the fair value of the assets and liabilities of the CMBS trusts and net interest earned on the consolidated CMBS trusts. See Note 4 to our consolidated financial statements for additional information.

Change in unrealized gain (loss) on CMBS structured pass-through certificates. Includes unrealized gain (loss) based on changes in the fair value of the CMBS I/O Strips. See Note 7 to our consolidated financial statements for additional information.

Change in unrealized gain on common stock investments. Includes unrealized gain (loss) based on changes in the fair value of our common stock investments in NSP and the Private REIT. See Note 5 to our consolidated financial statements for additional information.

Change in unrealized gain on preferred stock investments and stock warrants. Includes unrealized gain (loss) based on changes in the fair value of our preferred stock investments in IQHQ Series D and E and changes in the fair value of our stock warrants in IQHQ. See Note 5 to our consolidated financial statements for additional information.

Change in unrealized gain (loss) on MSCR Notes. Includes unrealized gain (loss) based on changes in the fair value of our MSCR Notes. See Note 7 to our consolidated financial statements for additional information.

Change in unrealized gain on mortgage backed securities. Includes unrealized gain (loss) based on changes in the fair value of our mortgage backed securities. See Note 7 to our consolidated financial statements for additional information.

Provision for (reversal of) credit losses, net. Provision for (reversal of) credit losses, net represents the change in our allowance for loan losses. See Note 2 to our consolidated financial statements for additional information.

Realized losses. Realized losses include the excess, or deficiency, of net proceeds received, less the carrying value of such investments, as realized losses. The Company reverses cumulative unrealized gains or losses previously reported in its Consolidated Statements of Operations with respect to the investment sold at the time of the sale.

Revenues from consolidated real estate owned (Note 8). Reflects the total revenues for our multifamily properties. Revenues include rental income from the multifamily properties.

Equity in Income (Losses) of Equity Method Investments. Equity in earnings (losses) of unconsolidated ventures represents the change in our basis in equity method investments resulting from our share of the investments’ income and expenses. Profit and loss from equity method investments for which we’ve elected the fair value option are classified in divided income, change in unrealized gains and realized gains as applicable.

Other income. Includes exit fees, placement fees and other miscellaneous income items.

Operating Expenses

G&A expenses. G&A expenses include, but are not limited to, audit fees, legal fees, listing fees, Board fees, equity-based and other compensation expenses, investor-relations costs and payments of reimbursements to our Manager. The Manager will be reimbursed for expenses it incurs on behalf of the Company. However, our Manager is responsible, and we will not reimburse our Manager or its affiliates, for the salaries or benefits to be paid to personnel of our Manager or its affiliates who serve as our officers, except that 50% of the salary of our VP of Finance is allocated to us and we may grant equity awards to our officers under the LTIP. Direct payment of operating expenses by us, which includes compensation expense relating to equity awards granted under the LTIP, together with reimbursement of operating expenses to our Manager, plus the Annual Fee, may not exceed 2.5% of equity book value determined in accordance with GAAP, for any calendar year or portion thereof, provided, however, that this limitation will not apply to Offering Expenses, legal, accounting, financial, due diligence and other service fees incurred in connection with extraordinary litigation and mergers and acquisitions and other events outside the ordinary course of our business or any out-of-pocket acquisition or due diligence expenses incurred in connection with the acquisition or disposition of certain real estate related investments. To the extent total corporate G&A expenses would otherwise exceed 2.5% of equity book value, our Manager will waive all or a portion of its Annual Fee to keep our total corporate G&A expenses at or below 2.5% of equity book value.

Loan servicing fees. We pay various service providers fees for loan servicing of our SFR Loans, mezzanine loans and consolidated CMBS trusts. We classify the expenses related to the administration of the SFR Loans and mezzanine loans as servicing fees while the fees associated with the CMBS trusts are included as a component of the change in net assets related to consolidated CMBS VIEs.

Management fees. Management fees include fees paid to our Manager pursuant to the Management Agreement.

Expenses from consolidated real estate owned (Note 8). Reflects the total expenses for our multifamily properties. Expenses include interest, real estate taxes and insurance, operating, general and administrative, management fees, depreciation and amortization, rate cap (income) expense, and debt service bridge expenses of the multifamily properties.

Results of Operations for the Three and Nine Months Ended September 30, 2025 and 2024

The following tables set forth a summary of our operating results for the three months ended September 30, 2025 and 2024 (in thousands):

For the Three Months Ended September 30, 2025 2024 $ Change % Change
Net interest income $12,497 $12,518 $(21) (0.2)%
Other income 46,717 18,659 28,058 150.4%
Operating expenses (8,352) (7,844) (508) 6.5%
Net income 50,862 23,333 27,529 118.0%
Net (income) loss attributable to Series A Preferred stockholders (874) (874) — —%
Net (income) loss attributable to Series B Preferred stockholders (7,174) (2,403) (4,771) 198.5%
Net (income) loss attributable to redeemable noncontrolling interests (7,782) (3,940) (3,842) 97.5%
Net income attributable to common stockholders $35,032 $16,116 $18,916 117.4%

The change in our net income for the three months ended September 30, 2025 as compared to the net income for the three months ended September 30, 2024 primarily relates to an increase in interest income due to higher yielding assets, as well as an increase in other income. Our net income attributable to common stockholders for the three months ended September 30, 2025 was approximately $35.0 million. We had approximately $12.5 million in net interest income, generated $46.7 million in other income, incurred operating expenses of $8.4 million, allocated $0.9 million of income to Series A Preferred stockholders, allocated $7.2 million of income to Series B Preferred stockholders, and allocated $7.8 million of income to redeemable noncontrolling interests for the three months ended September 30, 2025.

Revenues

Net interest income. Net interest income was $12.5 million for the three months ended September 30, 2025 compared to net interest income of $12.5 million for the three months ended September 30, 2024 which remained consistent between periods.

Other income. Other income was $46.7 million for the three months ended September 30, 2025 compared to $18.7 million for the three months ended September 30, 2024, which was an increase of approximately $28.1 million. This was primarily due to an increase in unrealized gain related to preferred stock and warrants, an increase in our provision for credit losses as a result due to an increase in specific reserves related to a preferred investment, gain on sale of real estate assets, dividend income and an increase in income of equity method investments between the periods.

Expenses

G&A expenses. G&A expenses were $3.4 million for the three months ended September 30, 2025 compared to $2.2 million for the three months ended September 30, 2024, which was an increase of approximately $1.2 million. The increase between the periods was primarily due to a $0.5 million increase in other expenses compared to the prior period as well as a $0.5 million increase in audit fees.

Loan servicing fees. Loan servicing fees were $0.4 million for the three months ended September 30, 2025 compared to $0.3 million for the three months ended September 30, 2024, which was an increase of approximately $0.1 million and primarily the result of increases in loan servicing rates.

Management fees. Management fees were $1.8 million for the three months ended September 30, 2025 compared to $1.0 million for the three months ended September 30, 2024, which was an increase of approximately $0.8 million. The increase between the periods was primarily due to an increase in Equity as defined by the Management Agreement.

Expenses from consolidated real estate owned. Expenses from consolidated real estate owned were $2.8 million for the three months ended September 30, 2025, compared to $4.3 million for the three months ended September 30, 2024, which was a decrease of approximately $1.5 million. The decrease between the periods is due to the Company selling Hudson Montford on July 22, 2025.

The following tables set forth a summary of our operating results for the nine months ended September 30, 2025 and 2024 (in thousands):

For the Nine Months Ended September 30, 2025 2024 $ Change % Change
Net interest income $36,075 $6,444 $29,631 459.8%
Other income 88,926 42,026 46,900 111.6%
Operating expenses (25,906) (27,664) 1,758 (6.4)%
Net income 99,095 20,806 78,289 376.3%
Net (income) loss attributable to Series A Preferred stockholders (2,622) (2,622) — —%
Net (income) loss attributable to Series B Preferred stockholders (17,256) (4,545) (12,711) 279.7%
Net (income) loss attributable to redeemable noncontrolling interests (15,383) (4,322) (11,061) 255.9%
Net income attributable to common stockholders $63,834 $9,317 $54,517 585.1%

The change in our net income for the nine months ended September 30, 2025 as compared to the net income (loss) for the nine months ended September 30, 2024 primarily relates to an increase in interest income due to higher yielding assets and a decrease in interest expense related to the repayment of one of our senior and mezzanine loans. Our net income attributable to common stockholders for the nine months ended September 30, 2025 was approximately $63.8 million. We had approximately $36.1 million in net interest income, and generated income of $88.9 million in other income, incurred operating expenses of $25.9 million, allocated $2.6 million of income to Series A Preferred stockholders, allocated $17.3 million of income to Series B Preferred stockholders, and allocated $15.4 million of income to redeemable noncontrolling interests for the nine months ended September 30, 2025.

Revenues

Net interest income. Net interest income was $36.1 million for the nine months ended September 30, 2025 compared to net interest income of $6.4 million for the nine months ended September 30, 2024, which was an increase of approximately $29.6 million. The increase between the periods is primarily due to increased income from investments in preferred equity loans and on the revolving credit facility.

Other income. Other income was $88.9 million for the nine months ended September 30, 2025 compared to $42.0 million for the nine months ended September 30, 2024, which was an increase of approximately $46.9 million. This was primarily due to an increase in unrealized gain related to preferred stock and warrants, an increase in our provision for credit losses due to an increase in specific reserves related to a preferred investment and an increase in dividend income, with an offset against the provision for expected credit losses.

Expenses

G&A expenses. G&A expenses were $9.7 million for the nine months ended September 30, 2025 compared to $9.5 million for the nine months ended September 30, 2024, which was an increase of approximately $0.1 million. The increase between the periods was primarily due to a $0.1 million increase in audit expense as compared to the prior period.

Loan servicing fees. Loan servicing fees were $1.1 million for the nine months ended September 30, 2025 compared to $1.3 million for the nine months ended September 30, 2024, which was a decrease of approximately $0.2 million. The decrease between the periods was primarily due to a decrease in SFR Loans in the portfolio compared to the prior period.

Management fees. Management fees were $4.8 million for the nine months ended September 30, 2025 compared to $2.8 million for the nine months ended September 30, 2024. The increase between the periods was primarily due to an increase in Equity as defined by the Management Agreement.

Expenses from consolidated real estate owned. Expenses from consolidated real estate owned were $10.4 million for the nine months ended September 30, 2025, compared to $14.1 million for the nine months ended September 30, 2024, which was a decrease of approximately $3.7 million. The decrease between the periods is due to the Company selling Hudson Montford on July 22, 2025.

Key Financial Measures and Indicators

As a real estate finance company, we believe the key financial measures and indicators for our business are earnings per share, dividends declared, EAD, CAD and book value per share.

Earnings Per Share and Dividends Declared

The following table sets forth the calculation of basic and diluted net income per share and dividends declared per share (in thousands, except per share data):

For the Three Months Ended September 30, 2025 2024 % Change
Net income attributable to common stockholders $35,032 $16,116 117.4%
Net income attributable to redeemable noncontrolling interests 7,782 3,940 97.5%
Net income attributable to Series B Preferred stockholders 7,174 2,403 198.5%
Weighted-average number of shares of common stock outstanding
Basic 17,722 17,461 1.5%
Diluted 43,854 30,468 43.9%
Net income per share, basic $1.98 $0.92 115.2%
Net income per share, diluted $1.14 $0.74 54.1%
Dividends declared per share $0.5000 $0.5000 —%
For the Nine Months Ended September 30, 2025 2024 % Change
Net income (loss) attributable to common stockholders $63,834 $9,317 585.1%
Net income attributable to redeemable noncontrolling interests 15,383 4,322 255.9%
Net income attributable to Series B Preferred stockholders 17,256 4,545 279.7%
Weighted-average number of shares of common stock outstanding
Basic 17,651 17,383 1.5%
Diluted 39,628 27,673 43.2%
Net income per share, basic $3.62 $0.54 570.4%
Net income per share, diluted $2.43 $0.54 350.0%
Dividends declared per share $1.5000 $1.5000 —%

Earnings Available for Distribution, Cash Available for Distribution and Adjusted Weighted Average Common Shares Outstanding - Diluted

EAD is a non-GAAP financial measure. We believe EAD serves as a useful indicator for investors in evaluating our performance and our long-term ability to pay distributions. EAD is defined as the net income (loss) attributable to our common stockholders computed in accordance with GAAP, including realized gains and losses not otherwise included in net income (loss), excluding any unrealized gains or losses or other similar non-cash items that are included in net income (loss) for the applicable reporting period, regardless of whether such items are included in other comprehensive income (loss), or in net income (loss) and adding back amortization of stock-based compensation. Net income (loss) attributable to common stockholders may also be adjusted for the effects of certain GAAP adjustments and transactions that may not be indicative of our current operations.

We use EAD to evaluate our performance which excludes the effects of certain GAAP adjustments and transactions that we believe are not indicative of our current operations and to assess our long-term ability to pay distributions. We believe providing EAD as a supplement to GAAP net income (loss) to our investors is helpful to their assessment of our performance and our long term ability to pay distributions. EAD does not represent net income or cash flows from operating activities and should not be considered as an alternative to GAAP net income, an indication of our GAAP cash flows from operating activities, a measure of our liquidity or an indication of funds available for our cash needs. Our computation of EAD may not be comparable to EAD reported by other REITs.

We also use EAD as a component of the management fee paid to our Manager. As consideration for the Manager’s services, we will pay our Manager an annual management fee of 1.5% of Equity, paid monthly, in cash or shares of our common stock at the election of our Manager. “Equity” means (a) the sum of (1) total stockholders’ equity immediately prior to the closing of our IPO, plus (2) the net proceeds received by us from all issuances of our equity securities in and after the IPO, plus (3) our cumulative EAD from and after the IPO to the end of the most recently completed calendar quarter, (b) less (1) any distributions to our holders of common stock from and after the IPO to the end of the most recently completed calendar quarter and (2) all amounts that we have paid to repurchase for cash the shares of our equity securities from and after the IPO to the end of the most recently completed calendar quarter. In our calculation of Equity, we will adjust our calculation of EAD to remove the compensation expense relating to awards granted under one or more of our long-term incentive plans that is added back in our calculation of EAD. Additionally, for the avoidance of doubt, Equity does not include the assets contributed to us in the Formation Transaction. For the purpose of calculating EAD for the management fee, net income (loss) attributable to common stockholders may be adjusted for the effects of certain GAAP adjustments and transactions that may not be indicative of our current operations, in each case after discussions between the Manager and the independent directors of our Board and approved by a majority of the independent directors of our Board.

CAD is a non-GAAP financial measure. We calculate CAD by adjusting EAD by adding back amortization of premiums, depreciation and amortization of real estate investment, amortization of deferred financing costs and by removing accretion of discounts. We use CAD to evaluate our performance and our current ability to pay distributions. We also believe that providing CAD as a supplement to GAAP net income (loss) to our investors is helpful to their assessment of our performance and our current ability to pay distributions. CAD does not represent net income or cash flows from operating activities and should not be considered as an alternative to GAAP net income, an indication of our GAAP cash flows from operating activities, a measure of our liquidity or an indication of funds available for our cash needs. Our computation of CAD may not be comparable to CAD reported by other REITs.

EAD per diluted common share and CAD per diluted common share are based on adjusted weighted average common shares outstanding - diluted. Adjusted weighted average common shares outstanding - diluted is a non-GAAP measure calculated by subtracting the dilutive effect of potential redemptions of Series B Preferred shares for shares of our common stock from weighted average common shares outstanding - diluted. We believe providing adjusted weighted average common shares outstanding - diluted and EAD per diluted common share and CAD per diluted common share based on adjusted weighted average common shares outstanding - diluted is helpful to our investors in their assessment of our performance without the potential dilutive effect of the Series B Preferred shares. We have the right to redeem the Series B Preferred shares for cash or shares of our common stock. Additionally, Series B Preferred redemptions are capped at 2% of the outstanding Series B Preferred shares per month, 5% per quarter and 20% per year. The Company maintains sufficient liquidity to pay cash to cover any redemptions up to the quarterly redemption cap. Further, it is the Company's intent to not settle Series B Preferred redemptions in shares of common stock when the Company's common stock price is below book value.

Adjusted weighted average common shares outstanding - diluted should not be considered as an alternative to the GAAP measures. Our computation of adjusted weighted average common shares outstanding - diluted may not be comparable to adjusted weighted average common shares outstanding - diluted reported by other companies.

EAD per diluted common share and CAD per diluted common share for periods prior to the second quarter of 2024 have not been updated to reflect this adjustment as the dilutive effect of the Series B Preferred redemptions were immaterial to prior periods.

The following table provides a reconciliation of EAD and CAD to GAAP net income including the dilutive effect of noncontrolling interests and adjusted weighted average common shares outstanding - diluted to weighted average common shares outstanding - diluted for the three and nine months ended September 30, 2025 and 2024 (in thousands, except per share amounts):

For the Three Months Ended September 30, 2025 2024 % Change
Net income attributable to common stockholders $35,032 $16,116 117.4%
Net income attributable to redeemable noncontrolling interests 7,782 3,940 97.5%
Adjustments
Amortization of stock-based compensation 1,504 1,411 6.6%
Provision for (reversal of) credit losses 15,680 (298) 5361.7%
Equity in (income) losses of equity method investments (12) 1,105 (101.1)%
Unrealized (gains) or losses (1) (48,344) (4,660) 937.4%
EAD $11,642 $17,614 (33.9)%
EAD per Diluted Common Share $0.51 $0.75 (32.3)%
Adjustments
Amortization of premiums 3,750 4,093 (8.4)%
Accretion of discounts (4,055) (7,071) 42.7%
Depreciation and amortization of real estate investments 620 1,099 (43.6)%
Amortization of deferred financing costs 137 12 1041.7%
CAD $12,094 $15,747 (23.2)%
CAD per Diluted Common Share $0.53 $0.67 (20.9)%
Weighted-average common shares outstanding - basic 17,722 17,461 1.5%
Weighted-average common shares outstanding - diluted 43,854 30,468 43.9%
Shares attributable to potential redemption of Series B Preferred (20,999) (7,049) (197.9)%
Adjusted weighted-average common shares outstanding - diluted 22,855 23,419 (2.4)%

(1) Unrealized gains are the net change in unrealized loss on investments held at fair value applicable to common stockholders.

For the Nine Months Ended September 30, 2025 2024 % Change
Net income attributable to common stockholders $63,834 $9,317 585.1%
Net income attributable to redeemable noncontrolling interests 15,383 4,322 255.9%
Adjustments
Amortization of stock-based compensation 4,475 4,663 (4.0)%
Provision for (reversal of) credit losses 24,589 (720) 3515.1%
Equity in (income) losses of equity method investments 952 3,997 (76.2)%
Unrealized (gains) or losses (1) (77,911) 543 (14448.3)%
EAD $31,322 $22,122 41.6%
EAD per Diluted Common Share (2) $1.37 $0.95 44.2%
Adjustments
Amortization of premiums 8,570 33,649 (74.5)%
Accretion of discounts (9,156) (14,644) 37.5%
Depreciation and amortization of real estate investments 2,313 4,499 -48.6%
Amortization of deferred financing costs 161 36 347.2%
CAD $33,210 $45,662 (27.3)%
CAD per Diluted Common Share (2) $1.45 $1.96 (26.0)%
Weighted-average common shares outstanding - basic 17,651 17,383 1.5%
Weighted-average common shares outstanding - diluted 39,628 27,673 43.2%
Shares attributable to potential redemption of Series B Preferred (16,710) (4,348) (284.3)%
Adjusted weighted-average common shares outstanding - diluted (2) 22,918 23,325 (1.7)%

(1) Unrealized gains are the net change in unrealized loss on investments held at fair value applicable to common stockholders.

(2) Starting in the second quarter of 2024, EAD per diluted common share, CAD per diluted common share and adjusted weighted average common shares outstanding - diluted do not include the dilutive effect of the potential redemption of Series B Preferred Stock for common shares. Periods prior to the second quarter of 2024 have not been updated to reflect this adjustment because the dilutive effect of potential Series B Preferred redemptions were immaterial to prior periods. For the three months ended March 31, 2024, the adjusted weighted average common shares outstanding - diluted does not exclude the dilutive effect of the potential redemption of Series B Preferred Stock for common shares.

Book Value per Share / Unit

The following table calculates our book value per share (in thousands, except per share data):

September 30, 2025 December 31, 2024
Common stockholders' equity $334,499 $295,624
Shares of common stock outstanding at period end 17,722 17,461
Book value per share of common stock $18.87 $16.93

59

Due to the large noncontrolling interest in the OP (see Note 13 to our consolidated financial statements for more information), we believe it is useful to also look at book value on a combined basis as shown in the table below (in thousands, except per share data):

September 30, 2025 December 31, 2024
Common stockholders' equity $334,499 $295,624
Redeemable noncontrolling interests in the OP 93,989 86,164
Total equity $428,488 $381,788
Redeemable OP Units at period end 5,038 5,038
Shares of common stock outstanding at period end 17,722 17,461
Combined shares of common stock and redeemable OP Units 22,760 22,499
Combined book value per share / unit $18.83 $16.97

Our Portfolio

Our portfolio consists of SFR Loans, CMBS B-Pieces, CMBS I/O Strips, mezzanine loans, preferred equity investments, common stock investments, preferred stock investments, multifamily properties, promissory notes, revolving credit facilities and stock warrants with a combined unpaid principal balance of $1.5 billion as of September 30, 2025 and assumes the CMBS Entities’ assets and liabilities are not consolidated. The following table sets forth additional information relating to our portfolio as of September 30, 2025 (dollars in thousands):

Investment (1) Senior Loans Investment Date Current Principal Amount Net Equity (2) Location Property Type Coupon Current Yield (3) Remaining Term (4) (years)
1 Senior Loan 2/11/2020 $7,688 $1,081 Various Single-family 5.35% 5.29% 2.34
2 Senior Loan 2/11/2020 5,056 588 Various Single-family 5.24% 5.06% 3.01
3 Senior Loan 2/11/2020 31,793 3,303 Various Single-family 4.74% 4.73% 0.17
4 Senior Loan 2/11/2020 9,253 1,041 Various Single-family 6.10% 5.87% 3.01
5 Senior Loan 2/11/2020 34,835 3,692 Various Single-family 5.55% 5.31% 3.09
6 Senior Loan 2/11/2020 5,447 617 Various Single-family 5.99% 5.75% 3.17
7 Senior Loan 2/11/2020 8,380 1,028 Various Single-family 5.88% 5.68% 3.26
8 Senior Loan 2/11/2020 6,268 797 Various Single-family 5.46% 5.30% 3.42
9 Senior Loan 2/11/2020 10,523 1,283 Various Single-family 4.72% 4.70% 0.42
Total 119,243 13,430 5.32% 5.18% 2.05
CMBS B-Pieces
1 CMBS B-Piece 2/11/2020 13,202 (5) 3,142 Various Multifamily 7.21% 7.21% 0.41
2 CMBS B-Piece 2/11/2020 28,581 (5) 6,984 Various Multifamily 6.07% 6.07% 1.15
3 CMBS B-Piece 7/30/2020 15,910 (5) (2,277) Various Multifamily 13.47% 13.47% 1.73
4 CMBS B-Piece 4/20/2021 14,714 (5) 3,727 Various Multifamily 10.60% 10.60% 5.41
5 CMBS B-Piece 6/30/2021 108,303 (5) 24,631 Various Multifamily —% 9.36% 1.25
6 CMBS B-Piece 5/2/2022 25,532 (5) 5,321 Various Multifamily 4.91% 5.24% 13.16
7 CMBS B-Piece 7/28/2022 53,691 (5) 13,497 Various Multifamily 9.60% 9.60% 3.82
8 CMBS B-Piece 2/22/2024 30,869 (5) 6,660 Various Multifamily 5.90% 6.59% 3.82
9 CMBS B-Piece 4/24/2024 31,931 (5) 7,566 Various Multifamily 5.59% 6.30% 3.48
Total 322,733 69,251 5.08% 8.39% 3.26
CMBS I/O Strips
1 CMBS I/O Strip 5/18/2020 17,590 (6) 283 Various Multifamily 2.02% 20.58% 4.32
2 CMBS I/O Strip 8/6/2020 108,643 (6) 3,116 Various Multifamily 2.98% 23.57% 4.74
3 CMBS I/O Strip 4/28/2021 63,181 (6) 852 Various Multifamily 1.59% 23.67% 4.32
4 CMBS I/O Strip 5/27/2021 20,000 (6) 650 Various Multifamily 3.38% 23.50% 4.65
5 CMBS I/O Strip 6/7/2021 4,266 (6) 60 Various Multifamily 2.31% 33.44% 3.16

60

6 CMBS I/O Strip 6/11/2021 85,340 (6) 515 Various Multifamily 1.69% 28.35% 3.65
7 CMBS I/O Strip 6/24/2021 19,384 (6) 274 Various Multifamily —% —% 4.65
8 CMBS I/O Strip 8/10/2021 25,000 (6) 362 Various Multifamily 1.89% 23.92% 4.57
9 CMBS I/O Strip 8/11/2021 6,942 (6) 262 Various Multifamily 3.10% 19.14% 5.82
10 CMBS I/O Strip 8/24/2021 1,625 (6) 43 Various Multifamily 2.61% 20.77% 5.32
11 CMBS I/O Strip 9/1/2021 34,625 (6) 641 Various Multifamily 1.92% 22.55% 4.74
12 CMBS I/O Strip 9/11/2021 20,902 (6) 760 Various Multifamily 2.95% 18.84% 5.99
13 CMBS I/O Strip 1/16/2025 15,000 (6) 1,440 Various Multifamily 5.67% 15.01% 9.16
14 CMBS I/O Strip 4/15/2025 15,327 (6) 1,352 Various Multifamily 5.69% 15.81% 8.57
Total 437,825 10,610 2.41% 22.51% 4.78
Mezzanine Loans
1 Mezzanine 6/12/2020 5,000 5,000 Houston, TX Multifamily 11.00% 11.00% 1.69
2 Mezzanine 10/20/2020 5,470 2,213 Wilmington, DE Multifamily 7.50% 7.38% 3.59
3 Mezzanine 10/20/2020 10,380 4,245 White Marsh, MD Multifamily 7.42% 7.27% 5.75
4 Mezzanine 10/20/2020 14,253 5,783 Philadelphia, PA Multifamily 7.59% 7.46% 3.67
5 Mezzanine 10/20/2020 3,700 1,492 Daytona Beach, FL Multifamily 7.83% 7.71% 3.01
6 Mezzanine 10/20/2020 12,000 4,904 Laurel, MD Multifamily 7.71% 7.55% 5.50
7 Mezzanine 10/20/2020 3,000 1,227 Temple Hills, MD Multifamily 7.32% 7.17% 5.84
8 Mezzanine 10/20/2020 1,500 614 Temple Hills, MD Multifamily 7.22% 7.07% 5.84
9 Mezzanine 10/20/2020 5,540 2,241 Lakewood, NJ Multifamily 7.33% 7.21% 3.59
10 Mezzanine 10/20/2020 6,829 2,757 North Aurora, IL Multifamily 7.53% 7.41% 3.26
11 Mezzanine 10/20/2020 3,620 1,480 Rosedale, MD Multifamily 7.42% 7.27% 5.75
12 Mezzanine 10/20/2020 9,610 3,930 Cockeysville, MD Multifamily 7.42% 7.27% 5.75
13 Mezzanine 10/20/2020 7,390 3,022 Laurel, MD Multifamily 7.42% 7.27% 5.75
14 Mezzanine 10/20/2020 1,190 481 Las Vegas, NV Multifamily 7.71% 7.59% 3.42
15 Mezzanine 10/20/2020 3,310 1,340 Atlanta, GA Multifamily 6.91% 6.80% 3.75
16 Mezzanine 10/20/2020 2,880 1,162 Des Moines, IA Multifamily 7.89% 7.77% 3.09
17 Mezzanine 10/20/2020 4,010 1,618 Urbandale, IA Multifamily 7.89% 7.77% 3.09
18 Mezzanine 11/18/2021 12,600 12,537 Irving, TX Multifamily —% —% 3.17
19 Mezzanine 12/29/2021 8,136 8,125 Rogers, AR Multifamily 15.30% 15.32% 0.28
20 Mezzanine 6/9/2022 (7) 4,500 4,497 Rogers, AR Multifamily —% —% 0.11
21 Mezzanine 8/1/2025 3,573 3,298 Beacon, NY Self-Storage 10.55% 11.43% 0.84
22 Mezzanine 1/26/2024 (8) 101,999 101,999 Cambridge, MA Life Science 14.00% 14.00% 1.36
Total 230,490 173,965 10.23% 10.18% 2.72
Preferred Equity
1 Preferred Equity 5/29/2020 (9) 12,735 12,735 Houston, TX Multifamily 11.00% 11.00% 4.59
2 Preferred Equity 9/29/2021 22,054 22,020 Holly Springs, NC Life Science 10.00% 10.02% 1.00
3 Preferred Equity 12/28/2021 11,377 11,377 Las Vegas, NV Multifamily 10.50% 10.50% 6.42
4 Preferred Equity 1/14/2022 35,181 35,168 Vacaville, CA Life Science 10.00% 10.00% 1.00
5 Preferred Equity 4/7/2022 3,903 3,879 Beaumont, TX Self-Storage 14.19% 14.28% 4.92
6 Preferred Equity 6/8/2022 4,480 4,454 Temple, TX Self-Storage 13.47% 13.55% 4.92
7 Preferred Equity 7/1/2022 10,000 9,966 Medley, FL Self-Storage 11.00% 11.04% 1.75
8 Preferred Equity 8/10/2022 8,500 8,500 Plano, TX Multifamily —% —% 0.15
9 Preferred Equity 9/30/2022 9,000 8,998 Fort Worth, TX Multifamily —% —% 0.00
10 Preferred Equity 10/19/2022 8,063 8,108 Woodbury, MN Life Science 10.00% 9.94% 1.00
11 Preferred Equity 2/10/2023 29,450 29,462 Forney, TX Multifamily 11.00% 11.00% 2.50
12 Preferred Equity 2/24/2023 28,970 28,975 Richmond, VA Multifamily 11.00% 11.00% 1.48
13 Preferred Equity 5/16/2023 20,945 20,820 Phoenix, AZ Single-family 13.50% 13.58% 1.58
14 Preferred Equity 5/17/2023 4,192 4,154 Houston, TX Life Science 13.00% 13.12% 0.23
15 Preferred Equity 6/28/2024 7,500 7,473 Knoxville, TN Marina 13.00% 13.05% 3.08
16 Preferred Equity 3/19/2025 5,428 5,427 Kuttawa, KY Marina 13.00% 13.00% 9.88
17 Preferred Equity 1/31/2025 1,200 1,200 Houston, TX Multifamily 14.00% 14.00% 2.50
18 Preferred Equity 10/5/2022 1,490 1,483 Kirkland, WA Multifamily 9.00% 9.04% 2.25
Total 224,468 224,199 10.32% 10.34% 2.18

61

Common Equity
1 Common Stock 11/6/2020 N/A 26,010 N/A Self-Storage N/A N/A N/A
2 Common Stock 4/14/2022 N/A 25,556 N/A Ground Lease N/A N/A N/A
3 Common Equity 2/10/2023 N/A — Forney, TX Multifamily N/A N/A N/A
4 Common Equity 2/24/2023 N/A — Richmond, VA Multifamily N/A N/A N/A
5 Common Equity 9/8/2023 N/A — Atlanta, GA Multifamily N/A N/A N/A
6 Common Equity 7/8/2025 N/A — Irving, TX Multifamily N/A N/A N/A
7 Membership Interest 4/9/2024 N/A 1,660 Various Multifamily N/A N/A N/A
Total 53,226
Preferred Stock
1 Preferred Stock 11/9/2023 N/A 18,702 Various Life Science 10.50% N/A N/A
2 Preferred Stock 1/2/2025 N/A 137,013 Various Life Science 16.50% N/A N/A
Total 155,715
Real Estate
1 Real Estate 12/31/2021 (10) N/A 188 Charlotte, NC Multifamily N/A N/A N/A
2 Real Estate 10/10/2023 (11) N/A (1,566) Atlanta, GA Multifamily N/A N/A N/A
Total (1,378)
Promissory Note
1 Promissory Note 7/10/2024 12,500 12,500 Various Single-family 15.00% 15.00% 0.78
2 Promissory Note 9/30/2025 3,000 3,000 Las Vegas, NV Multifamily 8.00% 8.00% 1.00
Total 15,500 15,500 13.65% 13.65% 0.82
Revolving Credit Facility
1 Revolving Credit Facility 12/31/2024 148,600 137,901 Various Life Science 13.50% 13.50% 2.25
Total 148,600 137,901 13.50% 13.50% 2.25
Stock Warrant
1 Stock Warrant 5/23/2024 N/A 116,228 Various Life Science N/A N/A N/A
Total 116,228

(1) Our total portfolio represents the current principal amount of the consolidated senior loans, CMBS I/O Strips, mezzanine loans, preferred equity, multifamily properties, promissory notes, revolving credit facilities and stock warrants as well as the net equity of our CMBS B-Piece investments.

(2) Net equity represents the carrying value less borrowings collateralized by the investment.

(3) Current yield is the annualized income earned divided by the cost basis of the investment.

(4) The weighted-average life is weighted on current principal balance and assumes no prepayments. The maturity date for preferred equity investments represents the maturity date of the senior mortgage, as the preferred equity investments require repayment upon the sale or refinancing of the asset.

(5) The CMBS B-Pieces are shown on an unconsolidated basis reflecting the value of our investments.

(6) The number shown represents the notional value on which interest is calculated for the CMBS I/O Strips. CMBS I/O Strips receive no principal payments and the notional value decreases as the underlying loans are paid off.

(7) The mezzanine loan term was extended effective April 9, 2025 to May 16, 2025, and extended further to November 10, 2025. The Company intends to extend the maturity to facilitate the sale of the property.

(8) Effective April 1, 2024, the Company reclassified this investment from a mezzanine loan to senior loan because there was no senior mortgage on the property collateralized by the loan. Effective September 30, 2025, the Company reclassified this investment back to a mezzanine loan because as of September 30, 2025 there is a senior mortgage on the property collateralized by the loan.

(9) The Company, through the Subsidiary OPs, invested $1.1 million in the year ended December 31, 2024 in this preferred equity investment.

(10) Real Estate is a 204-unit multifamily property the Company sold on July 22, 2025. The Company must include the net assets still owed in its financial statements pursuant to applicable accounting standards.

(11) Real Estate is a 280-unit multifamily property. As of September 30, 2025, the property was 94.6% occupied with effective rent per occupied unit of $1,617 per month.

The following table details overall statistics for our portfolio as of September 30, 2025 (dollars in thousands):

Total Portfolio Floating Rate Investments Fixed Rate Investments Common Equity Investments Real Estate Investments Stock Warrants
Number of investments 88 20 58 7 2 1
Principal balance (1) $1,110,823 $377,836 $732,986 N/A N/A N/A
Carrying value $1,574,961 $367,907 $973,290 $53,226 $64,310 $116,228
Weighted-average cash coupon 5.32% 5.61% 5.17% N/A N/A N/A
Weighted-average all-in yield 7.62% 10.77% 6.43% N/A N/A N/A

(1) Cost is used in lieu of notional value for CMBS I/O Strips.

Liquidity and Capital Resources

Our short-term liquidity requirements consist primarily of funds necessary to pay for our ongoing commitments to repay borrowings, maintain our investments, make distributions to our stockholders and other general business needs. Our investments generate liquidity on an ongoing basis through principal and interest payments, prepayments and dividends. We believe that our available cash, expected operating cash flows, and potential debt or equity financings will provide sufficient funds for our operations, anticipated scheduled debt service payments, any potential obligations to fulfill unfunded commitments and dividend requirements for the twelve-month period following September 30, 2025.

Our long-term liquidity requirements consist primarily of acquiring additional investments, scheduled debt payments and distributions. We expect to meet our long-term liquidity requirements through various sources of capital, which may include future debt or equity issuances, net cash provided by operations and other secured and unsecured borrowings. Our leverage is matched in term and structure to provide stable contractual spreads which will protect us from fluctuations in market interest rates over the long-term. However, there are a number of factors that may have a material adverse effect on our ability to access these capital sources, including the state of overall equity and credit markets, our degree of leverage, borrowing restrictions imposed by lenders, general market conditions for REITs and our operating performance and liquidity. We believe that our various sources of capital, which may include future debt or equity issuances, net cash provided by operations and other secured and unsecured borrowings, will provide sufficient funds for our operations, anticipated debt service payments, potential obligations to purchase investments under the Company's commitments noted in Note 15 to our consolidated financial statements and dividend requirements for the long-term.

Recent Tax Law Update

On July 4, 2025, President Trump signed into law the legislation known as the One Big Beautiful Bill Act (“the OBBBA”). The OBBBA made significant changes to the U.S. federal income tax laws in various areas. Among the notable changes, the OBBBA permanently extended certain provisions that were enacted in the Tax Cuts and Jobs Act of 2017, most of which were set to expire after December 31, 2025. These include the permanent extension of (i) the reduced marginal U.S. federal income tax rates and (ii) the 20% deduction on “qualified REIT dividends” for individuals and other non-corporate taxpayers and (iii) the limitation on non-corporate taxpayers using “excess business losses” to offset other income. The OBBBA also increased the percentage limit under the REIT asset test applicable to TRSs from 20% to 25% for taxable years beginning after December 31, 2025. As a result, for taxable years beginning after December 31, 2025, the aggregate value of all securities of TRSs held by a REIT may not exceed 25% of the value of its gross assets. We are currently evaluating the full potential impact of the provisions in the OBBBA, however, we do not expect it to have a material impact on our business.

The following table details the asset and debt metrics for the SFR and mezzanine loans as of September 30, 2025:

Investment SFR Loans Asset Metrics Fixed/Floating Rate Interest Rate Maturity Date Debt Metrics Fixed/Floating Rate Interest Rate Maturity Date Net Spread
Senior loan Fixed 5.35% 2/1/2028 Fixed 3.51% 2/1/2028 1.84%
Senior loan Fixed 5.24% 10/1/2028 Fixed 2.64% 10/1/2028 2.60%
Senior loan Fixed 4.74% 10/1/2025 Fixed 2.14% 10/1/2025 2.60%
Senior loan Fixed 6.10% 10/1/2028 Fixed 3.30% 10/1/2028 2.80%
Senior loan Fixed 5.55% 11/1/2028 Fixed 2.70% 11/1/2028 2.85%
Senior loan Fixed 5.99% 12/1/2028 Fixed 3.14% 12/1/2028 2.85%
Senior loan Fixed 5.88% 1/1/2029 Fixed 3.14% 1/1/2029 2.74%
Senior loan Fixed 5.46% 3/1/2029 Fixed 2.99% 3/1/2029 2.47%
Senior loan Fixed 4.72% 3/1/2026 Fixed 2.45% 3/1/2026 2.27%
Mezzanine Loans
Mezzanine Fixed 7.50% 5/1/2029 Fixed 0.30% 5/1/2029 7.20%
Mezzanine Fixed 7.42% 7/1/2031 Fixed 0.30% 7/1/2031 7.12%
Mezzanine Fixed 7.59% 6/1/2029 Fixed 0.30% 6/1/2029 7.29%
Mezzanine Fixed 7.83% 10/1/2028 Fixed 0.30% 10/1/2028 7.53%
Mezzanine Fixed 7.71% 4/1/2031 Fixed 0.30% 4/1/2031 7.41%
Mezzanine Fixed 7.32% 8/1/2031 Fixed 0.30% 8/1/2031 7.02%
Mezzanine Fixed 7.22% 8/1/2031 Fixed 0.30% 8/1/2031 6.92%
Mezzanine Fixed 7.33% 5/1/2029 Fixed 0.30% 5/1/2029 7.03%
Mezzanine Fixed 7.53% 7/1/2031 Fixed 0.30% 7/1/2031 7.23%
Mezzanine Fixed 7.42% 1/1/2029 Fixed 0.30% 1/1/2029 7.12%
Mezzanine Fixed 7.42% 7/1/2031 Fixed 0.30% 7/1/2031 7.12%
Mezzanine Fixed 7.42% 4/1/2031 Fixed 0.30% 4/1/2031 7.12%
Mezzanine Fixed 7.71% 3/1/2029 Fixed 0.30% 3/1/2029 7.41%
Mezzanine Fixed 6.91% 7/1/2029 Fixed 0.30% 7/1/2029 6.61%
Mezzanine Fixed 7.89% 11/1/2028 Fixed 0.30% 11/1/2028 7.59%
Mezzanine Fixed 7.89% 11/1/2028 Fixed 0.30% 11/1/2028 7.59%

Our primary sources of liquidity and capital resources to date consist of cash generated from our operating results and the following:

Freddie Mac Credit Facilities

Prior to the Formation Transaction, two of our subsidiaries entered into the Credit Facility. Under the Credit Facility, these entities borrowed approximately $788.8 million in connection with their acquisition of the Underlying Loans. No additional borrowings can be made under the Credit Facility, and our obligations will be secured by the Underlying Loans. The Credit Facility was assumed by the Company as part of the Formation Transaction. As such, the remaining outstanding balance of $788.8 million was contributed to the Company on February 11, 2020. Our borrowings under the Credit Facility will mature on July 12, 2029; however, if an Underlying Loan matures prior to July 12, 2029, we will be required to repay the portion of the Credit Facility that is allocated to that loan. As of September 30, 2025, the outstanding balance on the Credit Facility was $108.8 million.

Repurchase Agreements

From time to time, we may enter into repurchase agreements to finance the acquisition of our target assets. Repurchase agreements will effectively allow us to borrow against loans and securities that we own in an amount equal to (1) the market value of such loans and/or securities multiplied by (2) the applicable advance rate. Under these agreements, we will sell our loans and securities to a counterparty and agree to repurchase the same loans and securities from the counterparty at a price equal to the original sales price plus an interest factor. During the term of a repurchase agreement, we will receive the principal and interest on the related loans and securities and pay interest to the lender under the repurchase agreement. At any point in time, the amounts and the cost of our repurchase borrowings will be based on the assets being financed. For example, higher risk assets will result in lower advance rates (i.e., levels of leverage) at higher borrowing costs. In addition, these facilities may include various financial covenants and limited recourse guarantees.

As discussed in Note 9 to our consolidated financial statements, we, through the OP and the Subsidiary OPs, have borrowed approximately $257.6 million under our repurchase agreements and posted approximately $740.6 million par value of our CMBS B-Piece and CMBS I/O Strip investments as collateral. The CMBS B-Pieces and CMBS I/O Strips held as collateral are illiquid and irreplaceable in nature. These assets are restricted solely to satisfy the interest and principal balances owed to the lender.

The table below provides additional details regarding recent borrowings under the master repurchase agreements (in thousands):

Master Repurchase Agreements September 30, 2025 Facility Date issued Outstanding face amount Carrying value Final stated maturity Weighted average interest rate (1) Weighted average life (years) (2) Collateral Outstanding face amount Amortized cost basis Carrying value (3) Weighted average life (years) (2)
Mizuho(4) 4/15/2020 257,605 257,605 N/A (5) 5.96% 0.0 740,573 352,449 337,306 4.1

(1) Weighted-average interest rate using unpaid principal balances.

(2) Weighted-average life is determined using the maximum maturity date of the corresponding loans, assuming all extension options are exercised by the borrower.

(3) CMBS are shown at fair value on an unconsolidated basis.

(4) Borrowings under these repurchase agreements are collateralized by portions of the CMBS B-Pieces and CMBS I/O Strips.

(5) The master repurchase agreement with Mizuho does not have a stated maturity date. The transactions in place have a one-month to two-month tenor and are expected to roll accordingly

At-The-Market Offering

On March 15, 2022, the Company, the OP and the Manager separately entered into Equity Distribution Agreements with each of Raymond James, Keefe, Bruyette & Woods, Inc., Robert W. Baird & Co. Incorporated and Virtu Americas LLC, pursuant to which the Company may issue and sell from time to time under its ATM Program. The Equity Distribution Agreements provide for the issuance and sale of common stock or Series A Preferred Stock by the Company through a sales agent acting as a sales agent or directly to the sales agent acting as principal for its own account at a price agreed upon at the time of sale. As of September 30, 2025, pursuant to the Equity Distribution Agreements, the Company has sold 531,728 shares of its common stock and zero shares of Series A Preferred Stock for total gross sales of $12.6 million. For additional information about the ATM Program, see Note 11 to our consolidated financial statements.

Series B Preferred Stock Offering

On November 2, 2023, the Company announced the launch of a continuous public offering of up to 16,000,000 shares of its Series B Preferred Stock at a price to the public of $25.00 per share, for gross proceeds of $400.0 million. On October 1, 2025, the Company increased the size of the Series B Preferred Stock offering to 17,200,000 shares for gross proceeds of $430.0 million. Beginning on the first day of the calendar month following the date of original issuance, the Series B Preferred Stock are redeemable at the option of the holder at a redemption price per share equal to the liquidation preference of $25.00 per share, plus all accrued but unpaid cash dividends and less certain redemption fees. After the first day of the calendar month following the second anniversary of the original issue date, the Company also has the option to redeem, in whole or in part, subject to certain restrictions in the Company's charter and the articles supplementary setting forth the terms of the Series B Preferred Stock, at a redemption price per share equal to the liquidation preference of $25.00 per share, plus any accrued but unpaid cash dividends. In all optional redemptions, the Company has the right, in its sole discretion, to pay the redemption in cash or in equal value of shares of the Company’s common stock for so long as the common stock is listed or admitted to trading on the NYSE or another national securities exchange or automated quotation system. The Dealer Manager serves as the Company’s dealer manager in connection with the offering. The Dealer Manager uses its reasonable best efforts to sell the shares of Series B Preferred Stock offered in the offering, and the Company pays the Dealer Manager, subject to the discounts and other special circumstances described or referenced therein, (i) Selling Commissions of 7.0% of the aggregate gross proceeds from sales of Series B Preferred Stock in the offering and (ii) a Dealer Manager Fee of 3.0% of the gross proceeds from sales of Series B Preferred Stock in the offering. The Dealer

Manager, subject to federal and state securities laws, will reallow all or any portion of the Selling Commissions and may reallow a portion of the Dealer Manager Fee to other securities dealers that the Dealer Manager may retain who sold the shares of Series B Preferred Stock as is described more fully in the agreements between such dealers and the Dealer Manager. The Company expects that the offering will terminate on the earlier of the date the Company sells all 17,200,000 shares of the Series B Preferred Stock in the offering or December 29, 2026 (which is the third anniversary of the effective date of the Company’s registration statement), which may be extended by the Board in its sole discretion. The Board may elect to terminate this offering at any time. As of September 30, 2025, the Company has sold 13,717,142 shares of Series B Preferred Stock for total gross proceeds of $335.1 million.

Company Notes Offering

The Company has an aggregate principal amount of $180.0 million of its 5.75% Notes outstanding as of September 30, 2025.

OP Notes Offering

As of September 30, 2025, the OP had an aggregate principal amount of $36.5 million of its 7.50% OP Notes outstanding.

Subsequent to September 30, 2025, the OP issued a total of $45.0 million aggregate principal amount of its 2026 OP Notes for proceeds of approximately $43.9 million after original issue discount, the proceeds of which were used to repay the 7.50% OP Notes at maturity.

Other Potential Sources of Financing

We may seek additional sources of liquidity from further repurchase facilities, other borrowings and future offerings of common and preferred equity and debt securities and contributions from existing holders of the OP or Subsidiary OPs. In addition, we may apply our existing cash and cash equivalents and cash flows from operations to any liquidity needs. As of September 30, 2025, our cash and cash equivalents were $17.9 million.

Cash Flows

The following table presents selected data from our Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and September 30, 2024 (in thousands):

For the Nine Months Ended September 30, 2025 2025 2024
Net cash provided by operating activities $27,452 $24,925
Net cash provided by investing activities 279,659 735,935
Net cash (used in) financing activities (292,603) (738,802)
Net increase (decrease) in cash, cash equivalents, and restricted cash 14,508 22,058
Cash, cash equivalents and restricted cash, beginning of period 7,053 16,649
Cash, cash equivalents and restricted cash, end of period $21,561 $38,707

Cash flows from operating activities. During the nine months ended September 30, 2025, net cash provided by operating activities was $27.5 million compared to net cash provided by operating activities of $24.9 million for the nine months ended September 30, 2024. This increase primarily relates to the change in unrealized gains on investments held at fair value.

Cash flows from investing activities. During the nine months ended September 30, 2025, net cash provided by investing activities was $279.7 million compared to net cash provided by investing activities of $735.9 million for the nine months ended September 30, 2024. This decrease was primarily due to a decrease in proceeds from payments received on mortgage loans held for investment.

Cash flows from financing activities. During the nine months ended September 30, 2025, net cash used in financing activities was $292.6 million compared to net cash used in financing activities of $738.8 million for the nine months ended

September 30, 2024. The decrease primarily relates to a decrease of principal repayments on borrowings under secured financing agreements.

Emerging Growth Company and Smaller Reporting Company Status

Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Exchange Act, for complying with new or revised accounting standards applicable to public companies. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of this extended transition period. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates for such new or revised standards. We may elect to comply with public company effective dates at any time, and such election would be irrevocable pursuant to Section 107(b) of the JOBS Act. The Company expects to lose its emerging growth company status at December 31, 2025.

We are also a “smaller reporting company” as defined under the Exchange Act, and may elect to take advantage of certain of the scaled disclosures available to smaller reporting companies. We may be a smaller reporting company even after we are no longer an “emerging growth company.”

Dividends

We intend to make regular quarterly dividend payments to holders of our common stock. We also intend to make the accrued dividend payments on the Series A Preferred Stock, which are payable quarterly in arrears as provided in the articles supplementary setting forth the terms of the Series A Preferred Stock, and the Series B Preferred Stock, which are payable monthly as provided in the articles supplementary setting forth the terms of the Series B Preferred Stock. U.S. federal income tax law generally requires that a REIT distribute annually at least 90% of its REIT taxable income, without regard to the deduction for dividends paid and excluding net capital gains. As a REIT, we will be subject to U.S. federal income tax on our undistributed REIT taxable income and net capital gain and to a 4% nondeductible excise tax on any amount by which distributions we pay with respect to any calendar year are less than the sum of (1) 85% of our ordinary income, (2) 95% of our capital gain net income and (3) 100% of our undistributed income from prior years. We intend to make regular quarterly dividend payments of all or substantially all of our taxable income, which is not used to pay dividends on the Series A Preferred Stock and Series B Preferred Stock, to holders of our common stock out of assets legally available for this purpose, if and to the extent authorized by our Board. Before we make any dividend payments, whether for U.S. federal income tax purposes or otherwise, we must first meet both our operating requirements and debt service on our debt payable. If our cash available for distribution is less than our taxable income, we could be required to sell assets, borrow funds or raise additional capital to make cash dividends or we may make a portion of the required dividend in the form of a taxable distribution of stock or debt securities.

We will make dividend payments to holders of our common stock based on our estimate of taxable earnings per share of common stock, but not earnings calculated pursuant to GAAP. Our dividends and taxable income and GAAP earnings will typically differ due to items such as depreciation and amortization, fair-value adjustments, differences in premium amortization and discount accretion and non-deductible G&A expenses. Our quarterly dividends per share of our common stock may be substantially different than our quarterly taxable earnings and GAAP earnings per share.

Off-Balance Sheet Arrangements

As of September 30, 2025, we had one off balance sheet arrangement that has or is reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

On December 8, 2022, the Co-Guarantors, as guarantors, entered into the NSP Sponsor Guaranty Agreement in favor of Extra Space pursuant to which REIT Sub and the Co-Guarantors guaranteed obligations of NSP with respect to accrued dividends on NSP’s newly created Series D preferred stock and two promissory notes in an aggregate principal amount of approximately $64.2 million issued to Extra Space. The guaranties by REIT Sub and the Co-Guarantors are capped at $97.6 million, and each of REIT Sub and the Co-Guarantors generally guaranteed the foregoing obligations of NSP up to the cap amount on a pro rata basis with respect to its percentage ownership of NSP’s common stock. On February 15, 2023, NSP paid down approximately $15.0 million of these promissory notes, resulting in an aggregate principal amount of approximately $49.2 million. On December 8, 2023, NSP paid down the remaining principal balance of $49.2 million. The NSP Series D preferred stock remains outstanding as of September 30, 2025. As of September 30, 2025, the outstanding NSP Series D Preferred Stock accrued dividends was $14.1 million and the Company and NexPoint Diversified Real Estate Trust are jointly and severally liable for 85.90% of the guaranteed amount equal to $12.2 million.

Commitments and Contingencies

Except as otherwise disclosed below, the Company is not aware of any contractual obligations, legal proceedings or any other contingent obligations incurred in the normal course of business that would have a material adverse effect on our consolidated financial statements.

The Company provides certain guarantees in connection with the NSP Sponsor Guaranty Agreement. See Off-Balance Sheet Arrangements above for further details.

On March 14, 2023, the Company, through one of the Subsidiary OPs, committed to fund $24.0 million of preferred equity with respect to a ground up construction horizontal single-family property located in Phoenix, Arizona, of which $3.1 million was unfunded as of September 30, 2025. The preferred equity investment provides a floating annual return that is the greater of prime rate plus 5.0% or 11.25%, compounded monthly with a MOIC of 1.30x and 1.0% placement fee. The Company was also issued a common interest at the time of its first funding of preferred equity on May 16, 2023. The common interest allows the Company to receive a 10% profit share once aggregate distributions exceed the 20% internal rate of return IRR hurdle as shown below. There was no value ascribed to the common interest as of September 30, 2025. Further, once the Company's preferred equity and accrued interest has been repaid, any additional cash flow and net sale proceeds shall be distributed as follows:

  • 0% to the Company and 100% to issuer up to a 20% IRR
  • 10% to the Company and 90% to issuer thereafter

On February 10, 2023, the Company, through one of the Subsidiary OPs, through a unit purchase agreement, committed to purchase $30.3 million of the preferred units with respect to a multifamily property development located in Forney, Texas, which was fully funded as of September 30, 2025. Further, the Company committed to purchase $4.3 million of common equity with respect to the same property, of which $0.3 million was unfunded as of September 30, 2025.

On February 10, 2023, the Company, through one of the Subsidiary OPs, through a unit purchase agreement, committed to purchase $30.3 million of the preferred units with respect to a multifamily property development located in Richmond, Virginia, which has been fully funded as of September 30, 2025. Further, the Company committed to purchase $4.3 million of common equity with respect to the same property, of which $0.3 million was unfunded as of September 30, 2025.

SFR OP issued the SFR OP Note II to the Company on July 10, 2024. The SFR OP Note II bears interest at 15%, which is payable in kind, is interest only during the term of the SFR OP Note II and initially matured on July 10, 2025. On August 25, 2025, the Company, through REIT Sub. extended the maturity date to July 10, 2026 and increased the maximum amount available under the SFR OP Note II to $15.0 million. The Company funded $3.5 million through December 31, 2024. SFR OP paid down $1.9 million of principal on April 29, 2025. The Company funded $3.4 million, $5.0 million, $2.5 million on July 31, 2025, August 24, 2025 and September 24, 2025, respectively. The Company's maximum commitment under the loan is $15.0 million, of which $2.5 million was unfunded as of September 30, 2025.

On January 26, 2024, the Company, through OP IV, along with OSL, entered into the Alewife Loan whereby it made a loan in the maximum principal amount of up to $218.0 million to Alewife Holdings, which is solely owned by IQHQ, L.P. The Company has an ownership interest in the preferred stock in IQHQ, who is the limited partner in IQHQ, L.P.; however, the Company has no controlling financial interest nor significant influence in IQHQ, L.P.

On September 30, 2025, the Alewife Loan was bifurcated into (i) a senior mortgage loan in the maximum principal sum of $85.0 million (the "Alewife Senior Loan") and (ii) a mezzanine loan in the maximum principal sum of $133.0 million (the "Alewife Mezzanine Loan"). The Alewife Senior Loan was deemed fully funded, with the Company holding 73.5% of the Alewife Senior Loan based on prior fundings of the Alewife Loan of $62.5 million, and OSL holding 26.5% of the Alewife Senior Loan based on prior fundings of the Alewife Loan of $22.5 million. On September 30, 2025 the Company and OSL sold the Alewife Senior Loan. The Company's prior fundings of $102.0 million of the Alewife Loan were deemed fundings of the Alewife Mezzanine Loan, with the Company holding 100% of the Alewife Mezzanine Loan at closing. The Alewife Mezzanine Loan is secured by an equity pledge by Alewife Holdings of its equity interest in Alewife Member and an equity pledge by Alewife Member of its equity interest in Alewife. The Company's expected maximum commitment under the Alewife Mezzanine Loan is $133.0 million, of which $31.0 million was unfunded as of September 30, 2025.

On May 10, 2024, OP IV, NXDT OP and OSL entered into an Assignment and Assumption and Co-Lender Agreement, pursuant to which OP IV assigned the right to fund up to 9% of the Alewife Loan to NXDT OP and allocated the right to fund up to 9% of the Alewife Loan to OSL. Effective January 2, 2025, OP IV and OSL entered into an Assignment and Assumption and Co-Lender Agreement, pursuant to which OP IV assigned $7.5 million interest in the Alewife Loan to OSL for cash and increased OSL's allocation of the right to fund up to 10.32% of the Alewife Loan. In addition, under the Assignment Agreement, at any time and from time to time, NREF may purchase up to all of the amounts funded by OSL in the Alewife Loan from OSL. Upon receipt of a draw request, NXDT OP and OSL have the right to elect to fund an amount equal or greater than zero and up to (i) 9% or 10.32%, respectively, of the total amount of all advances previously made under the Alewife Loan plus the amount of the then current borrowing, (ii) less the total amount of advances previously made by NXDT OP and OSL, respectively. OP IV is required to fund any amounts not funded by OSL and NXDT OP. At any time that NXDT OP and OSL have funded less than their respective percentages of all advances made under the Alewife Loan, NXDT OP and OSL have the option upon notice to OP IV to pay to OP IV any amount of such unfunded amount. Upon such payment, NXDT OP or OSL would become entitled to all interest and fees accrued on the amount paid to OP IV on and after the date of such payment. The Company's expected maximum commitment under the Alewife Mezzanine Loan is $133.0 million, of which $31.0 million was unfunded as of September 30, 2025.

On May 23, 2024, Bridge Investor I entered into the Bridge Purchase Agreement whereby IQHQ, L.P. issued and sold to Bridge Investor I the IQHQ Promissory Note with a purchase commitment of $150.0 million. The IQHQ Promissory Note bore interest at 16.5%, which was payable in kind, and matured on May 23, 2025. The IQHQ Promissory Note would automatically convert into Series E of IQHQ upon a Qualified Equity Financing (as defined in the IQHQ Promissory Note). In accordance with the Bridge Purchase Agreement, IQHQ Holdings also issued and sold the IQHQ Bridge Warrant to Bridge Investor I to purchase Class A-3 Units of IQHQ. The IQHQ Bridge Warrant entitles the holder to purchase, at an exercise price of $0.01, Class A-3 Units of IQHQ Holdings initially intended to represent 6.25% of the fully diluted and outstanding common equity of IQHQ Holdings. The IQHQ Bridge Warrant is exercisable, in whole or in part, at any time, and expires on May 23, 2034, unless there is an earlier change of control, initial public offering or liquidation.

In connection with the Bridge Purchase Agreement, the IQHQ Participating Purchasers entered into a participation rights agreement with Bridge Investor I pursuant to which the Company and the IQHQ Participating Purchasers had a right to fund up to specified amounts of the IQHQ Promissory Note and the IQHQ Bridge Warrant. Upon receipt of a draw request, each IQHQ Participating Purchaser had the right to elect to fund an amount equal or greater than zero up to their respective preemptive right under the IQHQ Holdings or IQHQ, L.P. organizational documents less the total amount of advances previously made by such IQHQ Participating Purchaser and NXDT OP had the right to elect to fund an amount equal or greater than zero up to 50% of the total requested amount that is not funded by the IQHQ Participating Purchasers. The Company, through certain subsidiaries, was required to fund any amounts not funded by the IQHQ Participating Purchasers and NXDT OP. Bridge Investor I can allocate all or any portion of the IQHQ Warrant to any parties to the participation rights agreement. On December 2, 2024, the IQHQ Promissory Note was fully funded. The Company funded $148.6 million and the IQHQ Participating Purchasers funded $1.4 million.

On December 31, 2024, the Company, through OP IV and the OP, along with the IQHQ Participating Purchasers that funded the IQHQ Promissory Note and Bluerock Total Income+ Real Estate Fund (“Bluerock”) entered into a Revolving Credit Agreement (the “IQHQ Revolving Loan”) whereby it made a loan in the maximum principal amount of up to $300.0 million to IQHQ, L.P. In connection with the IQHQ Revolving Loan, the full $150 million of the principal amount of the IQHQ Promissory Note and the full $150 million of the principal amount of a promissory note held by Bluerock was substituted and exchanged for deemed borrowings under the IQHQ Revolving Loan, and the IQHQ Revolving Loan was fully funded on December 31, 2024. On September 30, 2025, the IQHQ Revolving Loan was amended and restated to, among other things, add a new lender and increase the aggregate amount of the loan to $440.0 million, with the new lender funding $100.0 million at closing and each of the Company and Bluerock committing to fund an additional $20.0 million during the commitment period subject to certain terms and conditions. The IQHQ Revolving Loan accrues interest at a rate per annum equal to 13.5% per annum, which, prior to September 30, 2025, was fully payable in kind and, on and after September 30, 2025 is payable 1.5% per annum in kind and 12% per annum in cash. The revolving period during which IQHQ, L.P. is permitted to borrow, repay and re-borrow loans, subject to satisfaction of certain conditions and payment of certain fees, will terminate on September 30, 2028, the maturity date of the IQHQ Revolving Loan. As of September 30, 2025, the Company holds 38.32% of the revolving commitment under the IQHQ Revolving Loan, with an unfunded commitment balance of $20.0 million.

In connection with the IQHQ Revolving Loan, on December 31, 2024, Bridge Investor I entered into the IQHQ Subscription Agreement whereby Bridge Investor I committed to purchase $160.1 million of Series E of IQHQ. Pursuant to the IQHQ Subscription Agreement, the full $10.1 million of the interest accrued on the IQHQ Promissory Note was substituted and exchanged for a deemed funding of $10.1 million under the IQHQ Subscription Agreement. In connection with the IQHQ Subscription Agreement, on December 31, 2024, Bridge Investor I also entered into the IQHQ Warrant Purchase Agreement whereby IQHQ Holdings issued and sold the IQHQ Series E Warrant. The IQHQ Series E Warrant entitles the holder to purchase, at an exercise price of $0.01, Class A-3 Units of IQHQ Holdings initially intended to represent up to 10.25% of the fully diluted and outstanding common equity of IQHQ Holdings. The IQHQ Series E Warrant is exercisable, in whole or in part, at any time, for ten years, unless there is an earlier change of control, initial public offering or liquidation.

In connection with the IQHQ Subscription Agreement and IQHQ Warrant Purchase Agreement, the Company, through certain subsidiaries, along with the IQHQ Participating Purchasers entered into a participation rights agreement with Bridge Investor I pursuant to which the Company and the IQHQ Participating Purchasers have a right to fund up to specified amounts of the Series E of IQHQ commitment and the IQHQ Series E Warrant. Upon receipt of a draw request, each IQHQ Participating Purchaser has the right to elect to fund an amount equal or greater than zero up to their respective preemptive right under the IQHQ Holdings or IQHQ, L.P. organizational documents less the total amount of advances previously made by such IQHQ Participating Purchaser. Upon receipt of a draw request, NXDT OP will also have the right to elect to fund an amount equal or greater than zero up to 50% of the total requested amount that is not funded by the IQHQ Participating Purchasers. The Company, through certain subsidiaries, would be required to fund any amounts not funded by the IQHQ Participating Purchasers and NXDT OP. At any time that the IQHQ Participating Purchasers have funded less than their respective participation amounts, the IQHQ Participating Purchasers have the option to pay the Company or NXDT OP (to the extent it has funded) any amount of such unfunded amount. Upon such payment, the IQHQ Participating Purchaser would become entitled to all interest accrued on the amounts paid to the Company or NXDT OP, if applicable, on and after the date of such payment. Bridge Investor I can allocate all or any portion of the IQHQ Warrant to any parties to the participation rights agreement.

IQHQ Holdings is the sole common stockholder of IQHQ, and the IQHQ Participating Purchasers own common equity in IQHQ Holdings and/or IQHQ, L.P. The Company has an ownership interest in the Series D-1 preferred stock in IQHQ, which is the limited partner in IQHQ, L.P.; however, the Company has no controlling financial interest nor significant influence in IQHQ, L.P.

The loan participation was considered a transfer of the IQHQ Promissory Note and the IQHQ Bridge Warrant and is considered a transfer of the Series E of IQHQ and the IQHQ Series E Warrant qualified as a sale under ASC 860, Transfers and Servicing, as (1) the transfer legally isolated the transferred assets from the transferor, (2) the transferee has the right to pledge or exchange the transferred assets and no condition both constrains the transferee’s right to pledge or exchange the assets and provides more than a trivial benefit to the transferor, and (3) the transferor does not maintain effective control over the transferred assets. The IQHQ Promissory Note was classified as Loans, held-for-investment, net, the Series E of IQHQ is classified as preferred stock and the IQHQ Bridge Warrant is classified as Stock warrant investments. The IQHQ Bridge Warrants are accounted for as investments in equity securities under ASC 321, Investments – Equity Securities, and the Company elected to use the fair value option. As a result, the IQHQ Bridge Warrants are being fair valued using an option pricing model that considers both short and long-term exit scenario. The model incorporates economic and control rights, marketability of the Units, and other market-derived metrics, applying discounts for lack of marketability and control due to the minority stake and absence of public trading options.

As of September 30, 2025, the Company has funded $137.0 million of IQHQ Subscription Agreement, with an unfunded commitment balance of $23.0 million.

The table below shows the Company's unfunded commitments by investment type as of September 30, 2025 and December 31, 2024 (in thousands):

Investment Type Unfunded Commitments September 30, 2025 Unfunded Commitments December 31, 2024
Loans $59,929 $64,217
Preferred Equity 3,055 7,874
Common Equity 1,536 2,536
Preferred Stock 23,000 150,000
$87,520 $224,627

Critical Accounting Policies and Estimates

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires our management to make judgments, assumptions and estimates that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate these judgments, assumptions and estimates for changes that would affect the reported amounts. These estimates are based on management’s historical industry experience and on various other judgments and assumptions that are believed to be reasonable under the circumstances. Actual results may differ from these judgments, assumptions and estimates. Below is a discussion of the accounting policies and estimates that involve significant estimation uncertainty that have or are reasonably likely to have a material impact on our financial condition or results of operations. A discussion of recent accounting pronouncements and our significant accounting policies, including further discussion of the accounting policies described below, can be found in Note 2 to our consolidated financial statements.

Allowance for Credit Losses

In periods ending on or prior to December 31, 2022, the Company, with the assistance of an independent valuations firm, performed a quarterly evaluation of loans classified as held for investment for impairment on a loan-by-loan basis in accordance with ASC 310-10-35, *Receivables, Subsequent Measurement (“*ASC 310-10-35”). If the Company determined that it was probable that it would be unable to collect all amounts owed according to the contractual terms of a loan, impairment of that loan was indicated. If a loan was considered to be impaired, the Company would establish an allowance for loan losses, through a valuation provision in earnings that reduced carrying value of the loan to the present value of expected future cash flows discounted at the loan’s contractual effective rate or the fair value of the collateral, if repayment was expected solely from the collateral. For non-impaired loans with no specific allowance the Company determined an allowance for loan losses in accordance with ASC 450-20, *Loss Contingencies (“*ASC 450-20”), which represented management’s best estimate of incurred losses inherent in the portfolio at the balance sheet date, excluding impaired loans and loans carried at fair value. Management considered quantitative factors likely to cause estimated credit losses, including default rate and loss severity rates. The Company also evaluated qualitative factors such as macroeconomic conditions, evaluations of underlying collateral, trends in delinquencies and non-performing assets. Increases to (or reversals of) the allowance for loan loss for the fiscal year ended December 31, 2022 and prior years are included in “Loan loss (provision)” on the accompanying Consolidated Statements of Operations.

In June 2016, the FASB issued ASU 2016-13, *Financial Instruments – Credit Losses on Financial Instruments (“*ASU 2016-13”), which establishes credit losses on certain types of financial instruments. The new approach changes the impairment model for most financial assets and requires the use of a CECL model for financial instruments measured at amortized cost and certain other instruments. This model applies to trade and other receivables, loans, debt securities, net investments in leases and off-balance sheet credit exposures (such as loan commitments, standby letters of credit and financial guarantees not accounted for as insurance) and requires entities to estimate the lifetime expected credit loss on such instruments and record an allowance that represents the portion of the amortized cost basis that the entity does not expect to collect.

We adopted ASU 2016-13 as of January 1, 2023. The implementation process included the utilization of loan loss forecasting models, updates to our loan credit loss policy documentation, changes to internal reporting processes and related internal controls, and overall operational readiness for our adoption of the new standard. We have implemented loan loss forecasting models for estimating expected life-time credit losses, at the individual loan level, for our loan portfolio. These models are also utilized for estimating expected life-time credit losses for unfunded loan commitments for which the Company has a present contractual obligation to extend the credit and the obligation is not unconditionally cancellable. The CECL forecasting methods used by the Company include (i) a probability of default and loss given default method using underlying third-party CMBS/Commercial Real Estate loan database with historical loan losses from 1998 to 2022, and (ii) probability weighted expected cash flow method, depending on the type of loan and the availability of relevant historical market loan loss data. We might use other acceptable alternative approaches in the future depending on, among other factors, the type of loan, underlying collateral, and availability of relevant historical market loan loss data. Significant inputs to our forecasting methods include (i) key loan-specific inputs such as loan-to-value, vintage year, loan-term, underlying property type, occupancy, geographic location, performance against the underwritten business plan, and our internal loan risk rating, and (ii) a macro-economic environment forecast. The cumulative effect of adoption of ASU 2016-13 as of January 1, 2023 was a $1.6 million reduction in retained earnings. The beginning allowance for credit loss as of January 1, 2025 was $1.4 million. The provision for credit losses of $24.6 million for the nine months ended September 30, 2025 is included in reversal of (provision for) credit losses on the accompanying Consolidated Statements of Operations, resulting in an ending allowance for credit loss of $26.0 million as of September 30, 2025.

Significant judgment is required in determining impairment and in estimating the resulting loss allowance, and actual losses, if any, could materially differ from those estimates.

Valuation of Common Equity, Preferred Stock and Warrants

As of September 30, 2025, the Company owns approximately 25.5% of the total outstanding shares of NSP and thus can exercise significant influence over NSP. The Company elected the fair-value option in accordance with ASC 825-10-10. On a quarterly basis, the Company, with the assistance of an independent third-party valuation firm, determines the fair value for subsequent measurement absent a readily available market price. The valuation is determined using widely accepted valuation techniques consistent with the principles of ASC 820. Specifically, these techniques include the discounted cash flow methodology whereby observable market terminal capitalization rates and discount rates are applied to projected cash flows generated by self-storage assets owned by NSP. The necessary inputs for the valuation include projected cash flows of NSP, terminal capitalization rates and discount rates. These inputs are reflective of public company comparables, but are assumptions and estimates. As a result, the determination of fair value involves significant estimation uncertainty because it involves subjective judgments and estimates that are based on unobservable inputs. For the nine months ended September 30, 2025, the unrealized loss related to the change in fair value estimate is $4.5 million. See Notes 5 and 10 to our consolidated financial statements for additional disclosures regarding the valuation of NSP.

As of September 30, 2025, the Company owns approximately 6.3% of the total outstanding common equity of the Private REIT. The Company records the Private REIT at fair value in accordance with ASC 321. The valuation is determined using a market approach. The necessary input for the valuation includes the yield of the Private REIT. As a result, the determination of fair value is uncertain because it involves subjective judgments and estimates that are unobservable. For the nine months ended September 30, 2025, the unrealized loss related to the change in fair value estimate is $1.4 million. See Notes 5 and 10 to our consolidated financial statements for additional disclosures regarding the valuation of the Private REIT.

As of September 30, 2025, the Company owns approximately 98.0% of the total outstanding common equity of each of RFGH and RTB and 79.1% of the total outstanding membership interests of CAP. The Company holds these equity method investments based on the Company's proportionate share of income (losses) for the nine months ended September 30, 2025. See Notes 5 and 6 to our consolidated financial statements for additional disclosures regarding the equity method investments.

As of September 30, 2025, the Company owns 11.8% of the total outstanding shares of the Series D-1 preferred stock in IQHQ. See Notes 5 and 10 to our consolidated financial statements for additional disclosures regarding the equity security investment in IQHQ.

As of September 30, 2025, the Company owns 46.8% of the total outstanding shares of the Series E Preferred Stock in IQHQ. See Notes 5 and 10 to our consolidated financial statements for additional disclosures regarding the equity security investment in IQHQ.

As of September 30, 2025, the Company owns 43.9 million warrants of IQHQ. See Notes 5 and 10 to our consolidated financial statements for additional disclosures regarding the equity security investment in IQHQ.

Considerations Related to Tightening Monetary Policy

The macroeconomic environment remains challenging as central banks have held interest rates high to combat inflation. The high rate environment, coupled with bank failures in early 2023 and ongoing economic uncertainty, has limited credit availability to commercial real estate. Less available and more expensive debt capital has had pronounced effects on the capital markets, making investments harder to finance. Similar factors also impact the timing of and proceeds generated from asset sales and our ability to obtain debt capital.

REIT Tax Election

We elected to be treated as a REIT for U.S. federal income tax purposes. To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement that we distribute at least 90% of our “REIT taxable income,” as defined by the Code, to our stockholders. Taxable income from certain non-REIT activities is managed through a TRS and is subject to applicable federal, state, and local income and margin taxes. We had no significant taxes associated with our TRS for the nine months ended September 30, 2025 and September 30, 2024. We believe that our organization and current and proposed method of operation will allow us to qualify for taxation as a REIT, but no assurance can be given that we will operate in a manner so as to qualify as a REIT.

Controls and procedures

As filed, 1,682 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) and Rule 15d-15(b) under the Exchange Act, our management, including our President and Chief Financial Officer, evaluated, as of September 30, 2025, the effectiveness of our disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) and Rule 15d-15(e). Based on that evaluation, our President and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2025, to provide reasonable assurance that information required to be disclosed by us in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the rules and forms of the Exchange Act and is accumulated and communicated to management, including the President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

We believe, however, that a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls systems are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, within a company have been detected.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 186 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to the risk factors previously disclosed under Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K filed with the SEC on March 27, 2025.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Net income3 months2025-07-01 to 2025-09-30$50.9mus-gaap:ProfitLoss
Net income9 months2025-01-01 to 2025-09-30$99.1mus-gaap:ProfitLoss
Diluted EPS3 months2025-07-01 to 2025-09-30$1.14us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2025-01-01 to 2025-09-30$2.43us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-07-01 to 2025-09-30$1.98us-gaap:EarningsPerShareBasic
Basic EPS9 months2025-01-01 to 2025-09-30$3.62us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-07-01 to 2025-09-3043,854,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2025-01-01 to 2025-09-3039,628,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2025-01-01 to 2025-09-30$27.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Dividends paid9 months2025-01-01 to 2025-09-30$26.0mus-gaap:PaymentsOfDividendsCommonStock
Cash and equivalentsAt period end2025-09-30$17.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2025-09-30$5.28bnus-gaap:Assets
Total liabilitiesAt period end2025-09-30$4.50bnus-gaap:Liabilities
Long-term debtAt period end2025-09-30$720.9mus-gaap:LongTermDebt
Shareholders' equityAt period end2025-09-30$375.4mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001628280-25-052000. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.